Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BYF&S reports

The limits of genetic screening: trisomy 21 after euploid preimplantation genetic testing for aneuploidy and negative noninvasive prenatal testing.

  1. 1Department of Obstetrics and Gynecology, Loyola University Medical Center, Maywood, IL.

Abstract

Objective

To describe a case of false-negative preimplantation genetic testing for aneuploidy (PGT-A) and noninvasive prenatal test (NIPT) resulting in a neonate born with Down Syndrome.Design

Case report.Subjects

A 40-year-old multiparous woman with in vitro fertilization pregnancy due to a history of tubal ligation presenting to an academic medical center.Exposure

Prenatal aneuploidy screening with PGT-A and cell-free DNA.Main outcome measures

PGT-A test was conducted on a day 5 blastocyst which resulted as euploid. Subsequent NIPT test was obtained at 10 weeks and reported low-risk results.Results

The patient underwent vacuum-assisted vaginal delivery of a liveborn male infant with features of Down Syndrome. Postnatal karyotype confirmed nonmosaic trisomy 21.Conclusion

PGT-A and NIPT are powerful tools used for risk reduction, but they do not eliminate risk.

Related

  1. Results from the VANISH study: A prospective multicenter study validating a single-nucleotide polymorphism-based noninvasive prenatal test to assess aneuploidy risk in surviving twins of vanishing twin pregnancies.
    Lorraine Dugoff, Sunni L Mumford, Meredith L Rochon +27
    Pregnancy (Hoboken, N.J.)Peer-reviewedCC BY-NC-NDFull textObstetrics, gynaecology & paediatricsEurope PMC
  2. Impact of Structured Prenatal Counseling on Decision-making and Psychological Outcomes in Indian Women with High-risk Aneuploidy Screening Results: A Prospective Cohort Study
    Surg Cdr Rahul Ashok Mahajan, Surg Cdr Hrishikesh Magdum, Surg Capt Aparna Krishnamurthy +2
    Journal of Marine Medical SocietyPeer-reviewedCC BY-NC-SAFull textObstetrics, gynaecology & paediatricsDOAJ
  3. Efficacy of preimplantation genetic testing for aneuploidy in improving pregnancy outcome among couples with azoospermia: study protocol for a multicenter, randomized controlled trial.
    Yaqiong He, Jiaan Huang, Junhao Yan +4
    Frontiers in endocrinologyPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCCrossref
  4. Preimplantation genetic testing for aneuploidy (PGT-A) vs. morphology-based blastocyst selection for transfer: cost-effectiveness analysis within Israel's publicly funded IVF system.
    Einat Zivi, Moshe Leshno, Ariel Hammerman +1
    Israel journal of health policy researchPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCPMC
  5. Cumulative live birth following preimplantation genetic testing for aneuploidy versus conventional IVF/ICSI in unexplained recurrent pregnancy loss: a retrospective cohort study with intention-to-treat and per-protocol analyses
    Dan Han, Zuying Xu, Wenqiang Shen +5
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossref
BibTeX
@article{law2026limits,
  title = {{The limits of genetic screening: trisomy 21 after euploid preimplantation genetic testing for aneuploidy and negative noninvasive prenatal testing.}},
  author = {Jennifer Law and Kyra Ramsey and Nicole Sprawka and Joana Perdigao},
  journal = {F\&S reports},
  year = {2026},
  month = jul,
  doi = {10.1016/j.xfre.2026.06.010},
  url = {https://europepmc.org/article/MED/42903648},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - The limits of genetic screening: trisomy 21 after euploid preimplantation genetic testing for aneuploidy and negative noninvasive prenatal testing.
AU  - Jennifer Law
AU  - Kyra Ramsey
AU  - Nicole Sprawka
AU  - Joana Perdigao
PY  - 2026
DA  - 2026/07/06
JO  - F&S reports
DO  - 10.1016/j.xfre.2026.06.010
UR  - https://europepmc.org/article/MED/42903648
AB  - Objective  To describe a case of false-negative preimplantation genetic testing for aneuploidy (PGT-A) and noninvasive prenatal test (NIPT) resulting in a neonate born with Down Syndrome.Design  Case report.Subjects  A 40-year-old multiparous woman with in vitro fertilization pregnancy due to a history of tubal ligation presenting to an academic medical center.Exposure  Prenatal aneuploidy screening with PGT-A and cell-free DNA.Main outcome measures  PGT-A test was conducted on a day 5 blastocyst which resulted as euploid. Subsequent NIPT test was obtained at 10 weeks and reported low-risk results.Results  The patient underwent vacuum-assisted vaginal delivery of a liveborn male infant with features of Down Syndrome. Postnatal karyotype confirmed nonmosaic trisomy 21.Conclusion  PGT-A and NIPT are powerful tools used for risk reduction, but they do not eliminate risk.
SN  - 2666-3341
ER  -